Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Cytomegalovirus Infection

Free Subscription Articles published in Transplant Proc Retrieve available abstracts of 44 articles: HTML format Text format

Single Articles

July 2018
1. KOMOROWSKA-JAGIELSKA K, Heleniak Z, Debska-Slizien A
   Cytomegalovirus Status of Kidney Transplant Recipients and Cardiovascular Risk.
   Transplant Proc. 2018;50:1868-1873.
   PubMed     Text format     Abstract available
   
   
   June 2018
2. HWANG SD, Lee JH, Lee SW, Kim JK, et al
   Effect of Low-Dose Vs Standard-Dose Valganciclovir in the Prevention of Cytomegalovirus Disease in Kidney Transplantation Recipients: A Systemic Review and Meta-Analysis.
   Transplant Proc. 2018 Jun 2. pii: S0041-1345(18)30067.
   PubMed     Text format     Abstract available
   
   
   April 2018
3. BOND MMK, Bond MMK, Sehn A, Dias VH, et al
   Cyclosporine Versus Tacrolimus: Which Calcineurin Inhibitor Has Influence on Cytomegalovirus Infection in Cardiac Transplantation?
   Transplant Proc. 2018;50:809-814.
   PubMed     Text format     Abstract available
   
   
   March 2018
4. DE GRACIA-GUINDO MDC, Ruiz-Fuentes MDC, Galindo-Sacristan P, Osorio-Moratalla JM, et al
   Cytomegalovirus Infection Monitoring Based on Interferon Gamma Release Assay in Kidney Transplantation.
   Transplant Proc. 2018;50:578-580.
   PubMed     Text format     Abstract available
   
   
   
5. CINTRA-CABRERA M, Suarez-Benjumea A, Bernal-Blanco G, Gonzalez-Roncero FM, et al
   Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review.
   Transplant Proc. 2018;50:575-577.
   PubMed     Text format     Abstract available
   
   
   January 2018
6. BARADHI KM, Aure RL, El-Amm JM
   High-dose Valganciclovir Treatment for Resistant Cytomegalovirus Colitis due to UL97 and UL54 Mutations.
   Transplant Proc. 2018;50:142-144.
   PubMed     Text format     Abstract available
   
   
   
7. NANMOKU K, Shinzato T, Kubo T, Shimizu T, et al
   Prevention of Late-Onset Cytomegalovirus Infection and Disease in Donor-Positive/Recipient-Negative Kidney Transplant Recipients Using Low-Dose Valganciclovir.
   Transplant Proc. 2018;50:124-129.
   PubMed     Text format     Abstract available
   
   
   December 2017
8. HALLECK F, Khadzhynov D, Schrezenmeier E, Lehner L, et al
   Prolonged Low-Dose Prophylaxis With Valganciclovir in Cytomegalovirus-Negative Recipients of Kidney Transplants From Cytomegalovirus-Positive Donors Allows Seroconversion and Prevents Cytomegalovirus Disease.
   Transplant Proc. 2017;49:2280-2284.
   PubMed     Text format     Abstract available
   
   
   October 2017
9. KAYA AH, Tekgunduz E, Akpinar S, Batgi H, et al
   Is Cytomegalovirus Surveillance Necessary for Patients With Low Reactivation Risk in an Autologous Hematopoietic Cell Transplantation Setting?
   Transplant Proc. 2017;49:1911-1915.
   PubMed     Text format     Abstract available
   
   
   
10. FAVI E, Santangelo R, Iesari S, Morandi M, et al
    Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience.
    Transplant Proc. 2017;49:1766-1772.
    PubMed     Text format     Abstract available
    
    
    September 2017
11. ECHENIQUE IA, Beltran D, Ramirez-Ruiz L, Najafian N, et al
    Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report.
    Transplant Proc. 2017;49:1560-1564.
    PubMed     Text format     Abstract available
    
    
    June 2017
12. BRUMINHENT J, Rotjanapan P, Watcharananan SP
    Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
    Transplant Proc. 2017;49:1048-1052.
    PubMed     Text format     Abstract available
    
    
    
13. HARADA S, Nakamura T, Ushigome H, Akutsu N, et al
    Beneficial Effects of High-Dose Mizoribine on ABO-Incompatible Living-Related Kidney Transplantation: Two-Year Results by a Japanese Multicenter Study.
    Transplant Proc. 2017;49:967-970.
    PubMed     Text format     Abstract available
    
    
    May 2017
14. BRASIL IRC, Custodio-Lima J, Sampaio RL, Pierre AMM, et al
    Pre-emptive Therapy for Cytomegalovirus in Post-transplantation Liver Patients With Donor-Positive/Recipient-Negative Serostatus.
    Transplant Proc. 2017;49:871-873.
    PubMed     Text format     Abstract available
    
    
    
15. PRETAGOSTINI R, Poli L, Lai Q, Russo G, et al
    Pre-Emptive Therapy for the Treatment of Cytomegalovirus After Kidney Transplantation.
    Transplant Proc. 2017;49:638-641.
    PubMed     Text format     Abstract available
    
    
    
16. PULITI REIGADA CH, de Ataide EC, de Almeida Prado Mattosinho T, Boin IFSF, et al
    Hepatic Artery Thrombosis After Liver Transplantation: Five-Year Experience at the State University of Campinas.
    Transplant Proc. 2017;49:867-870.
    PubMed     Text format     Abstract available
    
    
    April 2017
17. KIR O, Zeytinoglu A, Arda B, Yilmaz M, et al
    Impact of Prophylaxis vs Pre-emptive Approach for Cytomegalovirus Infection in Kidney Transplant Recipients.
    Transplant Proc. 2017;49:537-540.
    PubMed     Text format     Abstract available
    
    
    March 2017
18. RUAN V, Czer LS, Awad M, Kittleson M, et al
    Use of Anti-Thymocyte Globulin for Induction Therapy in Cardiac Transplantation: A Review.
    Transplant Proc. 2017;49:253-259.
    PubMed     Text format     Abstract available
    
    
    January 2017
19. SHI Y, Liu H, Chen XG, Shen ZY, et al
    Comparison of Mizoribine and Mycophenolate Mofetil With a Tacrolimus-Based Immunosuppressive Regimen in Living-Donor Kidney Transplantation Recipients: A Retrospective Study in China.
    Transplant Proc. 2017;49:26-31.
    PubMed     Text format     Abstract available
    
    
    November 2016
20. LUNA E, Caravaca F, Ferreira F, Fernandez N, et al
    Effect of Cytomegalovirus Infection on Survival of Older Kidney Transplant Patients (D+/R+): Impact of Valganciclovir Prophylaxis Versus Preemptive Therapy.
    Transplant Proc. 2016;48:2931-2937.
    PubMed     Text format     Abstract available
    
    
    
21. CARBONE J, Gallego A, Fernandez Yanez J, Sousa I, et al
    Potential Immunomodulatory Role of Specific Anticytomegalovirus Intravenous Immunoglobulin in Heart Recipients.
    Transplant Proc. 2016;48:3027-3029.
    PubMed     Text format     Abstract available
    
    
    October 2016
22. FENG S, Yang J, Wang W, Hu X, et al
    Incidence and Risk Factors for Cytomegalovirus Infection in Patients With Kidney Transplantation: A Single-Center Experience.
    Transplant Proc. 2016;48:2695-2699.
    PubMed     Text format     Abstract available
    
    
    July 2016
23. FAYEK SA, Beshears E, Lieber R, Alvey N, et al
    Extended Low-Dose Valganciclovir Is Effective Prophylaxis Against Cytomegalovirus in High-Risk Kidney Transplant Recipients With Near-Complete Eradication of Late-Onset Disease.
    Transplant Proc. 2016;48:2056-2064.
    PubMed     Text format     Abstract available
    
    
    June 2016
24. TARASEWICZ A, Debska-Slizien A, Rutkowski B
    Clinical Utility of QuantiFERON-Cytomegalovirus Test in Management of Kidney Transplant Recipients.
    Transplant Proc. 2016;48:1650-3.
    PubMed     Text format     Abstract available
    
    
    May 2016
25. KANG GW, Hong HL, Lee IH, Ahn KS, et al
    Ganciclovir and Foscarnet Therapy of Cytomegalovirus-Associated Meningoencephalitis in a Hemodialysis Patient With Liver Transplantation: Case Report.
    Transplant Proc. 2016;48:1208-11.
    PubMed     Text format     Abstract available
    
    
    
26. MATSUURA R, Maeda A, Sakai R, Eguchi H, et al
    Human HLA-Ev (147) Expression in Transgenic Animals.
    Transplant Proc. 2016;48:1323-5.
    PubMed     Text format     Abstract available
    
    
    April 2016
27. NAGANUMA T, Takemoto Y, Iwai T, Kuwabara N, et al
    Effects of Granulocyte and Monocyte Adsorptive Apheresis in Renal Transplantation Recipients With Concomitant Cytomegalovirus Infection.
    Transplant Proc. 2016;48:929-32.
    PubMed     Text format     Abstract available
    
    
    
28. IWAMOTO H, Nakamura Y, Konno O, Tomita K, et al
    Immunosuppressive Therapy for Elderly Kidney Transplant Recipients.
    Transplant Proc. 2016;48:799-801.
    PubMed     Text format     Abstract available
    
    
    
29. USHIGOME H, Uchida K, Nishimura K, Akioka K, et al
    Efficacy and Safety of High-Dose Mizoribine Combined With Cyclosporine, Basiliximab, and Corticosteroids in Renal Transplantation: A Japanese Multicenter Study.
    Transplant Proc. 2016;48:794-8.
    PubMed     Text format     Abstract available
    
    
    March 2016
30. AMBROSE T, Sharkey LM, Louis-Auguste J, Rutter CS, et al
    Cytomegalovirus Infection and Rates of Antiviral Resistance Following Intestinal and Multivisceral Transplantation.
    Transplant Proc. 2016;48:492-6.
    PubMed     Text format     Abstract available
    
    
    
31. ARZE S, Arze L, Abecia C
    Post-transplantation Infections in Bolivia.
    Transplant Proc. 2016;48:646-53.
    PubMed     Text format     Abstract available
    
    
    October 2015
32. CHIASAKUL T, Townamchai N, Jutivorakool K, Chancharoenthana W, et al
    Risk Factors of Cytomegalovirus Disease in Kidney Transplant Recipients: A Single-Center Study in Thailand.
    Transplant Proc. 2015;47:2460-4.
    PubMed     Text format     Abstract available
    
    
    July 2015
33. MADI N, Al-Qaser M, Edan R, Al-Nakib W, et al
    Clinical Utility of Viral Load in the Management of Cytomegalovirus Infection in Solid Organ Transplant Patients in Kuwait.
    Transplant Proc. 2015;47:1802-7.
    PubMed     Text format     Abstract available
    
    
    
34. SANTOS CA, Brennan DC, Olsen MA
    Accuracy of Inpatient International Classification of Diseases, Ninth Revision, Clinical Modification Coding for Cytomegalovirus After Kidney Transplantation.
    Transplant Proc. 2015;47:1772-6.
    PubMed     Text format     Abstract available
    
    
    June 2015
35. YALCI A, Celebi ZK, Ozbas B, Sengezer OL, et al
    Evaluation of Infectious Complications in the First Year After Kidney Transplantation.
    Transplant Proc. 2015;47:1429-32.
    PubMed     Text format     Abstract available
    
    
    
36. KELES Y, Tekin S, Duzenli M, Yuksel Y, et al
    Post-transplantation Malignancy After Kidney Transplantation in Turkey.
    Transplant Proc. 2015;47:1418-20.
    PubMed     Text format     Abstract available
    
    
    May 2015
37. JAVAD HOSSEINI SM, Nemati E, Behzadian F, Einollahi B, et al
    Evaluation of ganciclovir resistance in cytomegalovirus infection of renal transplant recipients in tehran.
    Transplant Proc. 2015;47:1140-2.
    PubMed     Text format     Abstract available
    
    
    
38. ESHRAGHI H, Hekmat R
    Which CMV viral load threshold should be defined as CMV infection in kidney transplant patients?
    Transplant Proc. 2015;47:1136-9.
    PubMed     Text format     Abstract available
    
    
    January 2015
39. MILINKOVIC M, Jovicic-Pavlovic S, Lausevic M, Durutovic O, et al
    Epidemic varicella zoster virus reactivation in renal transplant recipients: a case report.
    Transplant Proc. 2015;47:146-50.
    PubMed     Text format     Abstract available
    
    
    
40. GARCIA-PAJARES F, Santos-Santamarta F, Fernandez-Fontecha E, Sanchez-Ocana R, et al
    Severe anemia, gastric ulcer, pneumonitis and cholangitis in a liver transplant patient: multiple organic dysfunction and one etiology: a case report.
    Transplant Proc. 2015;47:136-8.
    PubMed     Text format     Abstract available
    
    
    December 2014
41. SMITH A, Couvillion R, Zhang R, Killackey M, et al
    Incidence and management of leukopenia/neutropenia in 233 kidney transplant patients following single dose alemtuzumab induction.
    Transplant Proc. 2014;46:3400-4.
    PubMed     Text format     Abstract available
    
    
    September 2014
42. QUAGLIA M, Cena T, Fenoglio R, Musetti C, et al
    Immune function assay (immunknow) drop over first 6 months after renal transplant: a predictor of opportunistic viral infections?
    Transplant Proc. 2014;46:2220-3.
    PubMed     Text format     Abstract available
    
    
    
43. SILVESTRE C, Furian L, Marson P, Tison T, et al
    Desensitization With Plasmapheresis and Anti-Cd20 for ABO Incompatible Kidney Transplantation From Living Donor: Experience of a Single Center in Italy.
    Transplant Proc. 2014;46:2209-13.
    PubMed     Text format     Abstract available
    
    
    July 2014
44. LAFTAVI MR, Pankewycz O, Gruessner A, Brian M, et al
    Long-term outcomes of pancreas after kidney transplantation in small centers: is it justified?
    Transplant Proc. 2014;46:1920-3.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: